Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies - A report from the Children's Cancer Group Study

Medical and Pediatric Oncology

Volumn 36, Issue 6, 2001, Pages 612-622

  Rudnick, Emily ^a   Khakoo, Yasmin ^b   Antunes, Nuno L ^c   Seeger, Robert C ^d   Brodeur, Garrett M ^c   Shimada, Hiroyuki ^e   Gerbing, Robert B ^f   Stram, Daniel O ^g   Matthay, Katherine K ^a,e  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e CHILDREN S ONCOLOGY GROUP   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antineuronal antibodies; Developmental delay; Neuroblastoma; Opsoclonus myoclonus ataxia

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOTROPIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; STEROID;

AGE; ARTICLE; ATAXIA; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FOLLOW UP; HUMAN; MYOCLONUS; NEUROBLASTOMA; NEUROLOGIC DISEASE; OPSOCLONUS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ATAXIA; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; NEURONS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 0035034752     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1138     Document Type: Article

References (32)

1. The neurobiology of the opsoclonus-myoclonus syndrome
2. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma
3. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma
4. Opsomyoclonus and Neuroblastoma
5. The immunopharmacology of the opsoclonus-myoclonus syndrome
6. Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome
7. Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G
8. Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma
9. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: A report from the Pediatric Oncology Group
10. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
11. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues
12. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: An analysis of antigenic targets in neural tissues
13. Anti-neurofilament protein antibodies in opsoclonus-myoclonus
14. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas
15. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
16. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene
17. Antineuronal antibodies in patients with neuroblastoma (NBT) and paraneoplastic opsoclonus-myoclonus (POM)
18. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative western blot analysis
19. Paraneoplastic anti-Hu serum: Studies on human tumor cell lines
20. Nonparametric estimation from incomplete observations
21. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group studies
22. Opsoclonus-ataxia due to childhood neural crest tumors: A chronic neurologic syndrome
23. Myoclonic encephalopathy of infancy: A 10 year review
24. Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome
25. Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma
26. Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus
27. Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome
28. Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus
29. Outcome of children with opsoclonus-myoclonus regardless of etiology
30. Myoclonic encephalopathy of infants or "dancing eyes syndrome." Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma)
31. Opsoclonus/myoclonus: Paraneoplastic syndrome of neuroblastoma
32. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer